MAUNA KEA TECHNOL.EO -04
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more
MAUNA KEA TECHNOL.EO -04 (1MK) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, MAUNA KEA TECHNOL.EO -04 (1MK) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MAUNA KEA TECHNOL.EO -04 - Net Assets Trend (None–None)
This chart illustrates how MAUNA KEA TECHNOL.EO -04's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MAUNA KEA TECHNOL.EO -04 (None–None)
The table below shows the annual net assets of MAUNA KEA TECHNOL.EO -04 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to MAUNA KEA TECHNOL.EO -04's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
MAUNA KEA TECHNOL.EO -04 Competitors by Market Cap
The table below lists competitors of MAUNA KEA TECHNOL.EO -04 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Purepoint Uranium Group Inc
OTCQB:PTUUF
|
$11.88 Million |
|
Conavi Medical Corp.
V:CNVI
|
$11.89 Million |
|
Kronologi Asia Bhd
KLSE:0176
|
$11.89 Million |
|
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret
IS:ANGEN
|
$11.89 Million |
|
CEO Event Medya AS
IS:CEOEM
|
$11.88 Million |
|
Yenher Holdings Bhd
KLSE:5300
|
$11.88 Million |
|
Star Diamond Corporation
PINK:SHGDF
|
$11.88 Million |
|
B+S Banksysteme Aktiengesellschaft
F:DTD2
|
$11.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MAUNA KEA TECHNOL.EO -04's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares MAUNA KEA TECHNOL.EO -04's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently MAUNA KEA TECHNOL.EO -04 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares MAUNA KEA TECHNOL.EO -04's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MAUNA KEA TECHNOL.EO -04 (1MK) | €- | N/A | N/A | $11.88 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |